Watson Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WATSON LABS INC, and what generic and branded alternatives to WATSON LABS INC drugs are available?
WATSON LABS INC has seventy-five approved drugs.
There are eleven tentative approvals on WATSON LABS INC drugs.
Drugs and US Patents for Watson Labs Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs Inc | PROPOFOL | propofol | INJECTABLE;INJECTION | 205307-001 | Dec 22, 2015 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Watson Labs Inc | EZETIMIBE AND SIMVASTATIN | ezetimibe; simvastatin | TABLET;ORAL | 202968-004 | Apr 26, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs Inc | ISOFLURANE | isoflurane | LIQUID;INHALATION | 074393-001 | May 12, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Watson Labs Inc | TICAGRELOR | ticagrelor | TABLET;ORAL | 208390-001 | Sep 4, 2018 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Watson Labs Inc | NEBIVOLOL HYDROCHLORIDE | nebivolol hydrochloride | TABLET;ORAL | 203683-003 | Nov 27, 2015 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Watson Labs Inc | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 202506-001 | Nov 25, 2020 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.